Valuation : InterCure Ltd.

Market Cap 19Cr 0 17Cr 16Cr 14Cr 27Cr 1.81TCr 27Cr 183.82Cr 71Cr 930.75Cr 72Cr 71Cr 3TCr P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 33Cr 0 28Cr 27Cr 24Cr 45Cr 3.1TCr 46Cr 314.25Cr 121.94Cr 1.59TCr 123.35Cr 120.66Cr 5.13TCr EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+2.47%
1 week-5.78%
Current month-7.36%
1 month+12.15%
3 months+8.84%
6 months+23.94%
Current year+2.72%
1 week 1,603
Extreme 1603
1,794
1 month 1,255
Extreme 1255
1,862
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,834.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 66 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Other

Chief Financial Officer

5,39,947 0.9874%
18/03/26 Other

Director

19,046 0.0348%
18/03/26 Other

Chief Executive Officer

1,72,85,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
+2.47%-5.78%-38.72%-43.80% 6.39Cr
+0.35%-0.17%+9.21%+210.40% 35Cr
0.00%-5.95%-28.18%-28.18% 16Cr
+1.01%+0.50%+12.36%+92.31% 14Cr
-2.27%+7.50%-37.68%-52.22% 8.94Cr
0.00%0.00%-50.00%-85.71% 2.53Cr
Average +0.26%-1.43%-22.17%+15.46% 13.93Cr
Weighted average by Cap. +0.27%-0.95%-7.94%+87.82%

Financials

2024 2025
Net sales 24Cr 0 21Cr 19Cr 18Cr 33Cr 2.26TCr 33Cr 228.5Cr 89Cr 1.16TCr 90Cr 88Cr 3.73TCr 27Cr 0 23Cr 22Cr 20Cr 37Cr 2.55TCr 37Cr 258.5Cr 100.31Cr 1.31TCr 101.46Cr 99Cr 4.22TCr
Net income -6.78Cr -0 -5.83Cr -5.49Cr -5.01Cr -9.38Cr -640.09Cr -9.41Cr -65Cr -25Cr -328.41Cr -25Cr -25Cr -1.06TCr -3.57Cr -0 -3.07Cr -2.89Cr -2.64Cr -4.94Cr -337.16Cr -4.95Cr -34Cr -13Cr -172.99Cr -13Cr -13Cr -557.28Cr
Net Debt 13Cr 0 11Cr 11Cr 9.82Cr 18Cr 1.25TCr 18Cr 127Cr 49Cr 643.08Cr 50Cr 49Cr 2.07TCr 14Cr 0 12Cr 11Cr 10Cr 19Cr 1.29TCr 19Cr 130.43Cr 51Cr 660.45Cr 51Cr 50Cr 2.13TCr
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
04/26/04 ILA 1,662.00 +2.47% 5,273
03/26/03 ILA 1,622.00 -3.68% 10,992
02/26/02 ILA 1,684.00 -1.69% 10,537
01/26/01 ILA 1,713.00 -4.52% 8,865
31/26/31 ILA 1,794.00 +1.70% 41,094
  1. Stock Market
  2. Stocks
  3. INCR Stock